Hanping Feng

university of maryland baltimore

H指数:36

被引数:4,133

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A competitive BB-ELISA for anti-toxin B neutralising antibodies in assessing risk of recurrent Clostridioides difficile infection: a retrospective cohort study from the MODIFY I and II trials

竞争性BB-ELISA法检测抗毒素B中和抗体以评估<em>Clostridioides difficile</em>复发性感染风险：来自MODIFY I和II试验的回顾性队列研究

Lancet Microbe

IF20.4

2026-09-300

OAAI

Dextran sodium sulfate confounds causal role of periodontitis in inflammatory bowel disease

右旋糖酐硫酸钠混淆了牙周炎在炎症性肠病中的因果作用

JOURNAL OF PERIODONTOLOGY

IF3.8

2025-12-010

OAAI

A High-Throughput Microbial Viability Assay to Evaluate Lyoprotectants for Live Biotherapeutic Products

一种高通量微生物存活能力测定方法，用于评估活体生物治疗产品中的抗冻剂

Molecular Pharmaceutics

IF4.5

2025-10-220

PRE

Development of a Dihydrofolate Reductase Selection System for Saccharomyces boulardii

构建酿酒酵母分离筛选系统的二氢叶酸还原酶系统

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

IF4.9

2025-02-270

Rodent Diets Incorporated with Live Biotherapeutic Products (LBPs): An Innovative Dosing Strategy to Support Preclinical Animal Studies on LBP Intervention

结合活生物治疗产品 (LBP) 的啮齿动物饮食: 支持LBP干预临床前动物研究的创新剂量策略

AAPS PHARMSCITECH

IF4

2025-02-040

PRE

Loratadine as an Anti-inflammatory Agent Against Clostridium difficile Toxin B

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2024-01-191

A fine-tuned yeast surface-display/secretion platform enables the rapid discovery of neutralizing antibodies against Clostridioides difficile toxins

MICROBIAL CELL FACTORIES

IF4.9

2023-09-252

Genistein Inhibits Clostridioides difficile Infection via Estrogen Receptors and Lysine-Deficient Protein Kinase 1

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2023-01-113

PRE

ADS024, a Bacillus velezensis strain, protects human colonic epithelial cells against C. difficile toxin-mediated apoptosis

FRONTIERS IN MICROBIOLOGY

IF4.5

2023-01-107

OAAI

Establishment of a gnotobiotic pig model of Clostridioides difficile infection and disease

GUT PATHOGENS

IF4

2022-06-063

OAAI

The development of live biotherapeutics against Clostridioides difficile infection towards reconstituting gut microbiota

GUT MICROBES

IF11

2022-03-2316

OAAI

Spray layering of human immunoglobulin G: Optimization of formulation and process parameters

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2021-12-016

PRE

A probiotic yeast-based immunotherapy against Clostridioides difficile infection

SCIENCE TRANSLATIONAL MEDICINE

IF14.6

2020-10-2875

OAAI

Therapeutic Mechanism of Macrophage Inflammatory Protein 1 α Neutralizing Antibody (CCL3) in Clostridium difficile Infection in Mice

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2019-12-0315

OAAI

Designed Ankyrin Repeat Protein (DARPin) Neutralizers of TcdB from Clostridium difficile Ribotype 027

MSPHERE

IF3.1

2019-10-3018

OAAI

Structure of the full-length Clostridium difficile toxin B

NATURE STRUCTURAL & MOLECULAR BIOLOGY

IF10.1

2019-07-1571

OAAI

DEVELOPING AAV-BASED GENE THERAPY FOR ADRENOLEUKODYSTROPHY (X-ALD)

CYTOTHERAPY

IF3.2

2019-05-010

PREAI

Host-targeted niclosamide inhibits C. difficile virulence and prevents disease in mice without disrupting the gut microbiota

NATURE COMMUNICATIONS

IF15.7

2018-12-0747

OAAI

Cysteine Protease-Mediated Autocleavage of Clostridium difficile Toxins Regulates Their Proinflammatory Activity

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY

IF7.4

2018-01-0112

OAAI

A Multiparticulate Delivery System for Potential Colonic Targeting Using Bovine Serum Albumin as a Model Protein

PHARMACEUTICAL RESEARCH

IF4.3

2017-08-1413

OAAI

Hanping Feng

个人简介

教育背景

工作经历

荣誉奖项

研究方向